Increasing Access to Genomic Testing in Europe

The role of national genomic initiatives in increasing uptake of Advanced Diagnostics

What are the measures that leading EU Member States have taken to pave the way toward wider access to genomic testing? Last month, Richard Charter, our Vice President MedTech Market Access – Europe & Asia Pacific, joined the podcast by EUCOPE – European Confederation of Pharmaceutical Entrepreneurs to discuss what else can be done to ensure that genomic testing becomes accessible to the patients.

Listen to the episode “Increasing Access to Genomic Testing in Europe: The role of national genomic initiatives in increasing uptake of Advanced Diagnostics” below:

The episode “Increasing Access to Genomic Testing in Europe: The role of national genomic initiatives in increasing uptake of Advanced Diagnostics” is also available on the following platforms:

Google Podcasts    Pocket Casts    RadioPublic   Spotify

Meet the guests of this episode:
Published on:
June 21, 2022
Richard Charter

Richard Charter

Vice President MedTech Market Access - Europe & Asia Pacific, Alira Health Richard Charter has 15 years of experience in financial economics, health economics, consulting, market access, and pricing for MedTech companies. Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare.
Caroline van der Meijden

Caroline van der Meijden

Director of Reimbursement EU, Agendia As an extension of her PhD in life sciences Caroline van der Meijden is an expert in Health Technology Assessment (HTA) with experience in both public and private sectors. Agendia is a global leader in innovative genomic technology and diagnostic tests for breast cancer.
Don Husereau

Don Husereau

Health Economist & Adjunct Professor at the University of Ottawa Don Husereau does freelance health care research, and works with private and public sector life sciences organizations to help them understand the value of health technology and its implications for health and innovation policy.
Matias Olsen

Matias Olsen

Public Affairs and Policy Manager at EUCOPE Matias Olsen supports EUCOPE on key topics, covering among others, EU HTA, advanced diagnostics, the Pharmaceutical Strategy, EU’s cancer plan, blood, tissues and cells legislation and relevant market access topics. He coordinates members’ thematic working groups, including the P&R/Market Access Working Group, the Genomics Working Group and the EU HTA Regulation Task Force.

Would you like to learn more about Advanced Diagnostics? Check out the episode of our podcast Transformation Talks “An Advanced Perspective on Advanced Diagnostics”!

Related news

Blog November 22, 2023
Technological Innovations in Diabetes Management Medical Devices
Discover the notable trends in the diabetes management devices market including glucose monitoring, insulin delivery and digital health.
Diabetes MedTech
Blog November 17, 2023
Misconceptions About Patient-Centric Co-Design
Many people have misconceptions about patient-centric co-design, and these misconceptions are holding companies back.
Co-Design Digital Health MedTech Patient Centricity Pharma
Events November 8, 2023
Spain Healthcare Innovation Summit
We will sponsor and speak at Spain Healthcare Innovation Summit, a premier event that brings together healthcare professionals from across Spain and beyond to discuss the latest developments(...)
Market Access Patient Centricity Spain
Multimedia October 24, 2023
Clinical Trials & Hospital Pilots
Kenny Carberry, VP, Business Development, Research & Clinical Development, joins the “Clinical Trials & Hospital Pilots” webinar as speaker.
Clinical Trials MedTech
Publications October 17, 2023
Trends and Challenges in Diabetes Management Devices
Our experts had a look at the Diabetes Management Devices Market and identified the current regulatory and market access trends and challenges in this PM360 article.
Diabetes Medical Devices MedTech
Blog October 16, 2023
How to Co-Design a Solution with Patients to Meet Their Needs
To learn how you can benefit from a co-design approach and how to get started, we spoke with two experts on patient engagement and co-design.
Digital Health MedTech Patient Centricity Patient Engagement Pharma
Blog October 16, 2023
Macro Market Trends Impacting Cardiology Medical Devices
This article describes four key macro trends as outlined in our report, Cardiology Medical Devices Market Trends 2023.
Cardiology Medical Devices MedTech
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.